Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Inventory: 2010-2024

Historic Change in Inventory for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to -$1.6 million.

  • China Pharma Holdings' Change in Inventory rose 84.66% to -$57,779 in Q3 2025 from the same period last year, while for Sep 2025 it was -$890,206, marking a year-over-year increase of 34.28%. This contributed to the annual value of -$1.6 million for FY2024, which is 9520.14% down from last year.
  • China Pharma Holdings' Change in Inventory amounted to -$1.6 million in FY2024, which was down 9,520.14% from $17,058 recorded in FY2023.
  • China Pharma Holdings' Change in Inventory's 5-year high stood at $17,058 during FY2023, with a 5-year trough of -$1.6 million in FY2024.
  • Over the past 3 years, China Pharma Holdings' median Change in Inventory value was -$689,104 (recorded in 2022), while the average stood at -$759,645.
  • Its Change in Inventory has fluctuated over the past 5 years, first soared by 102.48% in 2023, then plummeted by 9,520.14% in 2024.
  • Yearly analysis of 5 years shows China Pharma Holdings' Change in Inventory stood at -$807,592 in 2020, then declined by 25.30% to -$1.0 million in 2021, then soared by 31.90% to -$689,104 in 2022, then soared by 102.48% to $17,058 in 2023, then tumbled by 9,520.14% to -$1.6 million in 2024.